Physician profile
Achal Patel
NPI 1861123143
$1,825.28
in general payments reported to CMS, 2019-2025
11 companies · $527 in 2025
The $527 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $17.81 · 2024: $1,281 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,825.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $624.77 | 2023-2025 | |
| Aimmune Therapeutics, INC. | $439.55 | 2024 | |
| Ardelyx, INC. | $257.17 | 2024-2025 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $171.15 | 2024-2025 | Dupixent |
| Gilead Sciences, INC. | $81.23 | 2024-2025 | |
| Qol Medical, LLC | $80.76 | 2024-2025 | Sucraid, Sucraid |
| Janssen Biotech, INC. | $62.81 | 2025 | Tremfya |
| Phathom Pharmaceuticals, INC. | $40.35 | 2024 | Voquezna |
| Celltrion USA INC. | $32.24 | 2024 | Vegzelma |
| Madrigal Pharmaceuticals | $20.85 | 2025 | Rezdiffra |
| Intercept Pharmaceuticals, INC. | $14.40 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Achal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.